Novavax Inc. (NVAX)
NASDAQ: NVAX
· Real-Time Price · USD
8.55
0.21 (2.52%)
At close: Sep 26, 2025, 3:59 PM
8.59
0.47%
After-hours: Sep 26, 2025, 07:57 PM EDT
Nuvaxovid Sales Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | -2.09M | -610.12M | -100.34% |
| Mar 31, 2025 | 608.02M | 558.25M | +1121.57% |
| Dec 31, 2024 | 49.77M | 11.56M | +30.26% |
| Sep 30, 2024 | 38.21M | 18.31M | +91.97% |
| Jun 30, 2024 | 19.9M | -62.42M | -75.82% |
| Mar 31, 2024 | 82.32M | -169.13M | -67.26% |
| Dec 31, 2023 | 251.45M | 249.22M | +11170.82% |
| Sep 30, 2023 | 2.23M | -282.93M | -99.22% |
| Jun 30, 2023 | 285.16M | 292.62M | -3924.10% |
| Mar 31, 2023 | -7.46M | -295.24M | -102.59% |
| Dec 31, 2022 | 287.79M | -338.3M | -54.03% |
| Sep 30, 2022 | 626.09M | 570.64M | +1029.01% |
| Jun 30, 2022 | 55.45M | -530.17M | -90.53% |
| Mar 31, 2022 | 585.63M | n/a | n/a |